Business ❯ Biotechnology ❯ Pharmaceuticals

Vaccine Development

Moderna Novavax Acquisitions mRNA Technology Workforce Management COVID-19 Vaccines Mpox Vaccine Patent Lawsuits Pandemic Preparedness

Hemmati Emerges as Front-Runner to Lead FDA’s Vaccine and Biologics Center

HHS and the White House say the choice remains under review.

CEPI Taps Samsung Biologics to Pre-Position Rapid Vaccine Manufacturing for Future Outbreaks

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Moderna Secures $590M U.S. Grant to Advance Bird Flu Vaccine Development

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

Bavarian Nordic Secures Major Contract for Smallpox and Mpox Vaccines